Hims & Hers Health Inc. Forecast, price target & analysts
Hims & Hers Health Inc. Target price 2026 - Analyst rating & recommendation
Hims & Hers Health Inc. Classifications & Recommendation
Hims & Hers Health Inc. Price Target
| Target Price | $32.13 |
| Price | $29.47 |
| Potential |
9.03%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Hims & Hers Health Inc. 2027 .
The average Hims & Hers Health Inc. target price is $32.13.
This is
9.03%
register free of charge
$44.10
49.64%
register free of charge
$23.69
19.60%
register free of charge
|
|
| A rating was issued by 22 analysts: 9 Analysts recommend Hims & Hers Health Inc. to buy, 13 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hims & Hers Health Inc. stock has an average upside potential 2027 of
9.03%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.35 | 3.27 |
| 59.00% | 39.42% | |
| EBITDA Margin | 7.50% | 9.19% |
| 30.23% | 22.45% | |
| Net Margin | 5.47% | -3.65% |
| 35.94% | 166.75% |
19 Analysts have issued a sales forecast Hims & Hers Health Inc. 2026 . The average Hims & Hers Health Inc. sales estimate is
This results in the following potential growth metrics:
20 Analysts have issued an Hims & Hers Health Inc. EBITDA forecast 2026. The average Hims & Hers Health Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
18 Hims & Hers Health Inc. Analysts have issued a net profit forecast 2026. The average Hims & Hers Health Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.51 | -0.51 |
| 3.77% | 200.00% | |
| P/E | negative | |
| EV/Sales | 2.26 |
18 Analysts have issued a Hims & Hers Health Inc. forecast for earnings per share. The average Hims & Hers Health Inc. EPS is
This results in the following potential growth metrics and future valuations:
Hims & Hers Health Inc....
Current Hims & Hers Health Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 24 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 21 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 24 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 21 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 11 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
